RecallDepth
Class III Terminated

Diltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), and b) 500-count bottles (NDC 0378-5280-05), Rx only, Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV, 26505

This recall has been terminated (originally issued February 27, 2019).

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
February 13, 2019
Posted
February 27, 2019
Recall Number
D-0506-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
8,159 bottles
Firm Location
Morgantown, WV, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testing

Distribution

Throughout the United States

Lot / Code Info

Lot #: 3090167, Exp. October 2019

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls